Matt Tooth
Global Communications Director at Swedish Orphan Biovitrum AB (Sobi) - 23a Tomtebodavägen, Stockholm 112 76, SE
Matt Tooth's Colleagues at Swedish Orphan Biovitrum AB (Sobi)
Mahsa Heidari
Medical Science Manager Immunology Nordics and Baltics, Medical Lead Denmark
Matt Tooth's Contact Details
(468) 697-2000
Stockholm County, Sweden
Swedish Orphan Biovitrum AB (Sobi)
Matt Tooth's Company Details
Swedish Orphan Biovitrum AB (Sobi)
23a Tomtebodavägen, Stockholm 112 76, SE • 1940 EmployeesMajor Drugs
Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. We have a diversified and growth-oriented commercial product portfolio. Key therapeutic areas are Inflammation and Genetics & Metabolism. Our late stage pipeline includes three phase III programs with substantial potential. We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners. Our sales and marketing organization covers about 20 countries in Europe and a subsidiary in the US. We are also represented through partners in in the Middle East, Australia and New Zealand. In 2012, Sobi had total revenues of SEK 1.9 billion (€ 215 M) and about 480 employees. The share (STO: SOBI) is listed on NASDAQ OMX Stockholm. More information is available at www.sobi.com.